Anti-Proliferative Activity of Poloxamer Cobalt Ferrite Nanoparticles against Human Prostate Cancer (DU-145) Cells: In-Vitro Study

Prostate cancer is the second most frequent type of cancer death in men. This study refers to the novel hyperthermia application of poloxamer-coated cobalt ferrite as a new approach for thermal eradication of DU-145 human prostate cancerous cells under a radio frequency magnetic field (RF-MF). The h...

Full description

Bibliographic Details
Main Authors: Nazanin Oroskhani, Seyed Mohammad Amini, Sakine Shirvalilou, Mehdi Khodaie, Seyed Rabi Mahdavi
Format: Article
Language:English
Published: Hindawi-IET 2024-01-01
Series:IET Nanobiotechnology
Online Access:http://dx.doi.org/10.1049/2024/8929168
_version_ 1797238500266868736
author Nazanin Oroskhani
Seyed Mohammad Amini
Sakine Shirvalilou
Mehdi Khodaie
Seyed Rabi Mahdavi
author_facet Nazanin Oroskhani
Seyed Mohammad Amini
Sakine Shirvalilou
Mehdi Khodaie
Seyed Rabi Mahdavi
author_sort Nazanin Oroskhani
collection DOAJ
description Prostate cancer is the second most frequent type of cancer death in men. This study refers to the novel hyperthermia application of poloxamer-coated cobalt ferrite as a new approach for thermal eradication of DU-145 human prostate cancerous cells under a radio frequency magnetic field (RF-MF). The hydrothermal method was applied for the synthesis of cobalt ferrite nanoparticles. Then, the structure, size, and morphology of nanoparticle were characterized. The cytotoxicity of the synthesized nanoparticles and RF-MF exposure on DU-145 prostate cancer cells was investigated separately or in combination with colony formation methods and MTT [3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide] assay. Transmission electron microscopy (TEM) confirmed the spherical morphology of nanoparticles with a size of 5.5 ± 2.6 nm. The temperature of cells treated with nanoparticles under RF-MF reached 42.73 ± 0.2°C after 15 min. RF-MF treatment or nanoparticles have not affected cell viability significantly. However, the combination of them eradicated 53% ± 4% of cancerous cells. In-vitro hyperthermia was performed on human prostate cancer cells (DU-145) with cobalt ferrite nanoparticles at specific concentrations that demonstrated a decrease in survival fraction based on colony formation assay compared to cells that were treated alone with nanoparticles or with RF-MF.
first_indexed 2024-04-24T17:36:38Z
format Article
id doaj.art-d6eb7e7c968849c7ad5c9f81c57d1a8f
institution Directory Open Access Journal
issn 1751-875X
language English
last_indexed 2024-04-24T17:36:38Z
publishDate 2024-01-01
publisher Hindawi-IET
record_format Article
series IET Nanobiotechnology
spelling doaj.art-d6eb7e7c968849c7ad5c9f81c57d1a8f2024-03-28T05:00:32ZengHindawi-IETIET Nanobiotechnology1751-875X2024-01-01202410.1049/2024/8929168Anti-Proliferative Activity of Poloxamer Cobalt Ferrite Nanoparticles against Human Prostate Cancer (DU-145) Cells: In-Vitro StudyNazanin Oroskhani0Seyed Mohammad Amini1Sakine Shirvalilou2Mehdi Khodaie3Seyed Rabi Mahdavi4Department of Medical PhysicsRadiation Biology Research CenterFinetech in Medicine Research CenterMaterials Science and EngineeringDepartment of Medical PhysicsProstate cancer is the second most frequent type of cancer death in men. This study refers to the novel hyperthermia application of poloxamer-coated cobalt ferrite as a new approach for thermal eradication of DU-145 human prostate cancerous cells under a radio frequency magnetic field (RF-MF). The hydrothermal method was applied for the synthesis of cobalt ferrite nanoparticles. Then, the structure, size, and morphology of nanoparticle were characterized. The cytotoxicity of the synthesized nanoparticles and RF-MF exposure on DU-145 prostate cancer cells was investigated separately or in combination with colony formation methods and MTT [3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide] assay. Transmission electron microscopy (TEM) confirmed the spherical morphology of nanoparticles with a size of 5.5 ± 2.6 nm. The temperature of cells treated with nanoparticles under RF-MF reached 42.73 ± 0.2°C after 15 min. RF-MF treatment or nanoparticles have not affected cell viability significantly. However, the combination of them eradicated 53% ± 4% of cancerous cells. In-vitro hyperthermia was performed on human prostate cancer cells (DU-145) with cobalt ferrite nanoparticles at specific concentrations that demonstrated a decrease in survival fraction based on colony formation assay compared to cells that were treated alone with nanoparticles or with RF-MF.http://dx.doi.org/10.1049/2024/8929168
spellingShingle Nazanin Oroskhani
Seyed Mohammad Amini
Sakine Shirvalilou
Mehdi Khodaie
Seyed Rabi Mahdavi
Anti-Proliferative Activity of Poloxamer Cobalt Ferrite Nanoparticles against Human Prostate Cancer (DU-145) Cells: In-Vitro Study
IET Nanobiotechnology
title Anti-Proliferative Activity of Poloxamer Cobalt Ferrite Nanoparticles against Human Prostate Cancer (DU-145) Cells: In-Vitro Study
title_full Anti-Proliferative Activity of Poloxamer Cobalt Ferrite Nanoparticles against Human Prostate Cancer (DU-145) Cells: In-Vitro Study
title_fullStr Anti-Proliferative Activity of Poloxamer Cobalt Ferrite Nanoparticles against Human Prostate Cancer (DU-145) Cells: In-Vitro Study
title_full_unstemmed Anti-Proliferative Activity of Poloxamer Cobalt Ferrite Nanoparticles against Human Prostate Cancer (DU-145) Cells: In-Vitro Study
title_short Anti-Proliferative Activity of Poloxamer Cobalt Ferrite Nanoparticles against Human Prostate Cancer (DU-145) Cells: In-Vitro Study
title_sort anti proliferative activity of poloxamer cobalt ferrite nanoparticles against human prostate cancer du 145 cells in vitro study
url http://dx.doi.org/10.1049/2024/8929168
work_keys_str_mv AT nazaninoroskhani antiproliferativeactivityofpoloxamercobaltferritenanoparticlesagainsthumanprostatecancerdu145cellsinvitrostudy
AT seyedmohammadamini antiproliferativeactivityofpoloxamercobaltferritenanoparticlesagainsthumanprostatecancerdu145cellsinvitrostudy
AT sakineshirvalilou antiproliferativeactivityofpoloxamercobaltferritenanoparticlesagainsthumanprostatecancerdu145cellsinvitrostudy
AT mehdikhodaie antiproliferativeactivityofpoloxamercobaltferritenanoparticlesagainsthumanprostatecancerdu145cellsinvitrostudy
AT seyedrabimahdavi antiproliferativeactivityofpoloxamercobaltferritenanoparticlesagainsthumanprostatecancerdu145cellsinvitrostudy